Tiziana Life Sciences Stock Forecast
NASDAQ: TLSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 10:47 AM ET
TLSA analyst consensus
Consensus (2 analysts)
strong_buy
Avg. price target
$7.98+546.15%
- Strong buy 0
- Buy 2
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 2 Wall Street analysts covering Tiziana Life Sciences (2026-10-08), 2 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $7.98, with a high estimate of $8.98 and a low estimate of $6.99. The average target implies upside of 546.2% from the current price of $1.24.
The spread between the highest and lowest targets is 28.5%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for TLSA.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 2 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $6.99 | +465.99% |
| Average target | $7.98 | +546.15% |
| High target | $8.98 | +627.13% |